Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | ACP1 | P24666 | 1/20 | 0.38 |
| ▸ | CDC25B | P30305 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5228591 | 0.79 | CYP1A2 (0.45) | PTPN1ACP1CDC25BKDM4EUSP2 | |
| SCHEMBL19947501 | 0.79 | CYP1A2 (0.45) | PTPN1ACP1CDC25BKDM4EUSP2 | |
| SCHEMBL5257249 | 0.79 | CYP1A2 (0.45) | PTPN1ACP1CDC25BKDM4EUSP2 | |
| SCHEMBL7764623 | 0.78 | PTPN1 (0.35) | PTPN1ACP1CDC25B | |
| SCHEMBL24326704 | 0.77 | CYP1A2 (0.36) | PTPN1ACP1CDC25BCA2CYP1A2 | |
| SCHEMBL14351681 | 0.76 | CA2 (0.36) | PTPN1ACP1CDC25BKDM4EUSP2 | |
| SCHEMBL1107556 | 0.74 | LMNA (0.51) | PTPN1ACP1CDC25BUSP2ALDH1A1 | |
| SCHEMBL22107643 | 0.74 | LMNA (0.51) | PTPN1ACP1CDC25BUSP2ALDH1A1 | |
| SCHEMBL5728565 | 0.74 | LMNA (0.51) | PTPN1ACP1CDC25BUSP2ALDH1A1 | |
| SCHEMBL1556220 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814498-B2 | Polylactone foams and methods of making the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814498-B2 | Polylactone foams and methods of making the same | NOVOMER, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20210324168-A1 | POLYLACTONE FOAMS AND METHODS OF MAKING THE SAME | NOVOMER, INC. | 2021-10-21 | — | — | US | disclosed |
| US-20210277028-A1 | METAL-ORGANIC FRAMEWORK CATALYSTS, AND USES THEREOF | NOVOMER, INC. | 2021-09-09 | — | — | US | disclosed |
| US-10961209-B2 | Processes for producing beta-lactone and beta-lactone derivatives with heterogenous catalysts | NOVOMER, INC. (US) | 2021-03-30 | — | — | US | disclosed |
| US-20200331876-A1 | ISOCYANATES, DERIVATIVES, AND PROCESSES FOR PRODUCING THE SAME | NOVOMER, INC. | 2020-10-22 | — | — | US | disclosed |
| US-10676426-B2 | Acrylonitrile derivatives from epoxide and carbon monoxide reagents | NOVOMER, INC. (US) | 2020-06-09 | — | — | US | disclosed |
| US-10590099-B1 | Processes for producing beta-lactone with heterogenous catalysts | NOVOMER, INC. (US) | 2020-03-17 | — | — | US | disclosed |
| US-20190002400-A1 | Acrylonitrile Derivatives from Epoxide and Carbon Monoxide Reagents | NOVOMER, INC. (US) | 2019-01-03 | — | — | US | disclosed |
| US-20190002293-A1 | Biobased Carbon Fibers and Carbon Black and Methods of Making the Same | NOVOMER, INC. (US) | 2019-01-03 | — | — | US | disclosed |
| US-7875734-B2 | such as fluoro-containing 2-propiolactone, formed in glass reactor via carbonylation at low pressure carbon monoxide | CORNELL RESEARCH FOUNDATION, INC. (US) | 2011-01-25 | — | — | US | disclosed |
| US-7875734-B2 | such as fluoro-containing 2-propiolactone, formed in glass reactor via carbonylation at low pressure carbon monoxide | CORNELL RESEARCH FOUNDATION, INC. (US) | 2011-01-25 | — | — | US | disclosed |
| US-20090287000-A1 | LOW PRESSURE CARBONYLATION OF HETEROCYCLES | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-11-19 | — | — | US | disclosed |
| US-20090287000-A1 | LOW PRESSURE CARBONYLATION OF HETEROCYCLES | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-11-19 | — | — | US | disclosed |
| US-7569709-B2 | Low pressure carbonylation of heterocycles | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-08-04 | — | — | US | disclosed |
| US-7569709-B2 | Low pressure carbonylation of heterocycles | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-08-04 | — | — | US | disclosed |
| US-20070213524-A1 | Low pressure carbonylation of heterocycles | CORNELL RESEARCH FOUNDATION, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| US-20070213524-A1 | Low pressure carbonylation of heterocycles | CORNELL RESEARCH FOUNDATION, INC. (US) | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10676426-B2 | Acrylonitrile derivatives from epoxide and carbon monoxide reagents | POR, AGL, ALK | SMN1; SMN2 3757/4885PTPN1 4238/4885ACP1 1885/4885 |
| US-20090287000-A1 | LOW PRESSURE CARBONYLATION OF HETEROCYCLES | CBR1, CYCS, PTGIS | SMN1; SMN2 3076/4885PTPN1 3584/4885ACP1 1031/4885 |
| US-20200331876-A1 | ISOCYANATES, DERIVATIVES, AND PROCESSES FOR PRODUCING THE SAME | IDH1, IDH2, IDH3A | SMN1; SMN2 1481/4885PTPN1 4631/4885ACP1 3398/4885 |
| US-10590099-B1 | Processes for producing beta-lactone with heterogenous catalysts | HBZ, AGL, RIOX2 | SMN1; SMN2 4101/4885PTPN1 4371/4885ACP1 3372/4885 |
| US-20190002293-A1 | Biobased Carbon Fibers and Carbon Black and Methods of Making the Same | AGL, CBR1, FASN | SMN1; SMN2 3923/4885PTPN1 4678/4885ACP1 1844/4885 |
| US-20070213524-A1 | Low pressure carbonylation of heterocycles | CBR1, CYCS, PTGIS | SMN1; SMN2 3076/4885PTPN1 3584/4885ACP1 1031/4885 |
| US-11814360-B2 | Isocyanates, derivatives, and processes for producing the same | IDH1, IDH2, IDH3A | SMN1; SMN2 1481/4885PTPN1 4631/4885ACP1 3398/4885 |
| US-20210277028-A1 | METAL-ORGANIC FRAMEWORK CATALYSTS, AND USES THEREOF | PPOX, PCCA, MCCC2 | SMN1; SMN2 4663/4885PTPN1 4881/4885ACP1 2092/4885 |
| US-20190002400-A1 | Acrylonitrile Derivatives from Epoxide and Carbon Monoxide Reagents | POR, AGL, ALK | SMN1; SMN2 3757/4885PTPN1 4238/4885ACP1 1885/4885 |
| US-10961209-B2 | Processes for producing beta-lactone and beta-lactone derivatives with heterogenous catalysts | AGL, HBZ, RIOX2 | SMN1; SMN2 4033/4885PTPN1 4249/4885ACP1 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.